ArticlePloS one2014

BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo.

Longchuan Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.